Jeffrey Schneider, MD, chief of hematology and medical oncology, Winthrop University Hospital, discusses the benefits of Myriad's myPlan in determining high-risk patients with non-small cell lung cancer (NSCLC).
Jeffrey Schneider, MD
Articles by Jeffrey Schneider, MD
Latest Updated Articles
The Benefits of myPlan to Help Identify High-Risk Patients With NSCLCNovember 23rd 2016